Mednet Logo
SpecialtiesAllergy & Immunology
Allergy & Immunology

Allergy & Immunology

Expert discussions on allergic conditions, immunodeficiencies, drug hypersensitivity, and immunotherapy approaches.

Recent Discussions

How long do you try an inhaler before increasing the dose because it was inadequate/failed to control the patients asthma?

1
1 Answers

Mednet Member
Mednet Member
Allergy & Immunology · Family Allergy And Asthma

ICS inhalers should improve asthma control in weeks, not months, especially in steroid naive patients.

Do you routinely recommend epinephrine auto-injectors for patients with isolated oral allergy syndrome, or only when there are risk factors for progression to systemic reactions?

1 Answers

Mednet Member
Mednet Member
Allergy & Immunology · Family Allergy And Asthma

What are those risk factors?

What role do you feel topical steroids play in the management of atopic dermatitis with the growing availability of non-steroid topicals?

2
1 Answers

Mednet Member
Mednet Member
Dermatology · University of Arkansas for Medical Sciences

Corticosteroids remain my first-line topical treatment for atopic dermatitis due to their availability, cost, and efficacy. Obviously, topical corticosteroids are not an ideal long-term treatment for continuous use due to their cumulative local toxicity. Calcineurin inhibitors are more sustainable i...

Do you reflexively test for tree nut allergies when you diagnose a peanut allergy?

1
2 Answers

Mednet Member
Mednet Member
Allergy & Immunology · University of Chicago

My decision to test tree nuts when a patient is diagnosed with a peanut allergy depends on multiple factors. In the past, children diagnosed with a peanut allergy were told to avoid all tree nuts due to the risk of co-existent allergy. That practice evolved over time as more research was conducted. ...

How do you time concurrent therapy with rituximab and IVIG?

7
2 Answers

Mednet Member
Mednet Member
Allergy & Immunology · University Hospitals Cleveland Medical Center

Rituximab has about the same half-life as regular IgG. If the regular IVIG treatment can be delayed, it will be less likely to increase the catabolism of Rituximab. If the regular IgG is given at 3-4 week intervals, I would give the Rituxan halfway between IVIG doses. Complement is needed for optima...

How would you approach diagnosis of a patient with recurrent episodes of abdominal pain, severe myalgias, low grade fevers and urticaria?

3
5 Answers

Mednet Member
Mednet Member
Rheumatology · University of Chicago

Without the mEFV variant, from a rheumatologist viewpoint, the differential includes IBD, a periodic fever syndrome such as FMF or FCAS, and MCAS. Therefore, I would consider that workup with genetic testing (anyone can send!), fecal calprotectin, and MCAS eval with A/I. I don't think of urticarial ...

In a patient with eosinophilic asthma that is controlled daily in between exacerbations, but has very symptomatic exacerbations which lead to ER visits and steroid bursts about 2 to 3 times per year, would you consider starting a biologic agent for prevention of exacerbations even though outside of flares patient is controlled?

2
1 Answers

Mednet Member
Mednet Member
Allergy & Immunology · University of Washington School of Medicine

A pragmatic approach to a patient like this is consideration of SMART (Single Maintenance And Reliever Therapy) with a single inhaler containing inhaled corticosteroid (ICS) and formoterol. Although controlled most of the time, the exacerbation profile suggests suboptimal control of inflammation at ...

Is there a role for nitazoxanide for treatment of norovirus gastroenteritis in immunocompromised patients?

1
2 Answers

Mednet Member
Mednet Member
Infectious Disease · National Institute of Allergy and Infectious Diseases (NIAID)

There is no good-quality evidence supporting a role for nitazoxanide for treatment of norovirus gastroenteritis in immunocompromised patients. The efficacy of nitazoxanide in viral gastroenteritis is supported by a small manufacturer-sponsored randomized, double-blind trial in non-immunocompromised ...

In a patient with multiple organ abscesses, no known predisposing factors, negative genetic panel testing for CGD and normal oxidative burst, what other testing modalities should be considered?

1 Answers

Mednet Member
Mednet Member
Allergy & Immunology · Uk Healthcare Asthma Allergy And Sinus Clinic

I would work the patient up for CVID. Also, I would find all the culture and sensitivity results to ensure it’s not MRSA. Also, culture results may open the door to other etiologies.

Why do foods seem to not have a refractory period when performing testing as is often the case with venom testing?

1 Answers

Mednet Member
Mednet Member
Allergy & Immunology · Johns Hopkins University School of Medicine

This is one of 2 important misconceptions about food anaphylaxis. There is actually good evidence of a refractory (anergic) period after anaphylaxis to foods, drugs, and peri-operative agents, but it is only about 7-10 days (and variable among individuals) rather than 4-6 weeks, as widely stated. It...